Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis

Eliabe S. Abreu, Mazen Noureddin, Hirokazu Takahashi, Jörn M. Schattenberg, Manal F. Abdelmalek

Open source

DOI
10.1016/j.cld.2026.01.004
Published
2026-05
Container
Clinics in Liver Disease
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cld.2026.01.004,
  title = {Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis},
  author = {Eliabe S. Abreu and Mazen Noureddin and Hirokazu Takahashi and Jörn M. Schattenberg and Manal F. Abdelmalek},
  year = {2026},
  journal = {Clinics in Liver Disease},
  doi = {10.1016/j.cld.2026.01.004},
  url = {https://doi.org/10.1016/j.cld.2026.01.004}
}

RIS

TY  - JOUR
TI  - Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis
AU  - Eliabe S. Abreu
AU  - Mazen Noureddin
AU  - Hirokazu Takahashi
AU  - Jörn M. Schattenberg
AU  - Manal F. Abdelmalek
PY  - 2026
JO  - Clinics in Liver Disease
DO  - 10.1016/j.cld.2026.01.004
UR  - https://doi.org/10.1016/j.cld.2026.01.004
ER  - 

APA

Abreu, E. S., Noureddin, M., Takahashi, H., Schattenberg, J. M., & Abdelmalek, M. F. (2026). Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2026.01.004

Source records